Panagora Asset Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Panagora Asset Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,350	Closed	-$1K	–	2754
2020 Q2	$1K	Hold	1,350	–	–	﹤0.01%	2524
2020 Q1	$0	Hold	1,350	–	–	﹤0.01%	2593
2019 Q4	$0	Sell	1,350 -114,987	-99%	-$26.4K	﹤0.01%	2561
2019 Q3	$21K	Hold	116,337	–	–	﹤0.01%	2068
2019 Q2	$24K	Hold	116,337	–	–	﹤0.01%	2243
2019 Q1	$19K	Hold	116,337	–	–	﹤0.01%	2274
2018 Q4	$38K	Buy	+116,337	New	+$37.3K	﹤0.01%	2037

Other funds holding RVPHW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Panagora Asset Management's RVPHW Position: Q3 2020 in Review

Panagora Asset Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2020, closing a stake of 1,350 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in RVPHW in Q4 2018 and held it in 7 quarters. The position peaked at $38K in Q4 2018. 14 funds tracked by Wall St. Rank hold RVPHW as of Q3 2020.

Panagora Asset Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2020 after selling out during the quarter.
Panagora Asset Management sold 1,350 Reviva Pharmaceuticals Warrants shares in Q3 2020, an estimated $1K.
Panagora Asset Management first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 7 quarters.
Panagora Asset Management's Reviva Pharmaceuticals Warrants position peaked at $38K in Q4 2018.
14 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.